Gastroenterology
Volume 130, Issue 6 , Pages 1886-1900 , May 2006

Toll-Like Receptor Signaling in the Liver

  • Robert F. Schwabe

      Affiliations

    • Corresponding Author InformationAddress requests for reprints to: Robert F. Schwabe, Department of Medicine, Columbia University, College of Physicians and Surgeons, P&S 9-460, 630 W. 168th Street, New York, New York 10032. fax: (212) 305-9822
    • ,
  • Ekihiro Seki
    • ,
  • David A. Brenner

References 

  1. Aderem A , Ulevitch RJ . Toll-like receptors in the induction of the innate immune response . Nature . 2000;406:782–787
  2. Janeway CA , Medzhitov R . Innate immune recognition . Annu Rev Immunol . 2002;20:197–216
  3. Lemaitre B , Nicolas E , Michaut L , Reichhart JM , Hoffmann JA . The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults . Cell . 1996;86:973–983
  4. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, et al. The evolution of vertebrate Toll-like receptors . Proc Natl Acad Sci U S A . 2005;102:9577–9582
  5. Schnare M , Barton GM , Holt AC , Takeda K , Akira S , Medzhitov R . Toll-like receptors control activation of adaptive immune responses . Nat Immunol . 2001;2:947–950
  6. Mathison JC , Ulevitch RJ . The clearance, tissue distribution, and cellular localization of intravenously injected lipopolysaccharide in rabbits . J Immunol . 1979;123:2133–2143
  7. Ruiter DJ, van der Meulen J, Brouwer A, Hummel MJ, Mauw BJ, van der Ploeg JC, et al. Uptake by liver cells of endotoxin following its intravenous injection . Lab Invest . 1981;45:38–45
  8. Benacerraf B , Sebestyen MM , Schlossman S . A quantitative study of the kinetics of blood clearance of P32-labelled Escherichia coli and Staphylococci by the reticuloendothelial system . J Exp Med . 1959;110:27–48
  9. Fox ES , Thomas P , Broitman SA . Clearance of gut-derived endotoxins by the liver. Release and modification of 3H, 14C-lipopolysaccharide by isolated rat Kupffer cells . Gastroenterology . 1989;96:456–461
  10. Gregory SH , Wing EJ . Neutrophil-Kupffer-cell interaction in host defenses to systemic infections . Immunol Today . 1998;19:507–510
  11. van Egmond M, van Garderen E, van Spriel AB, Damen CA, van Amersfoort ES, van Zandbergen G, et al. FcαRI-positive liver Kupffer cells (reappraisal of the function of immunoglobulin A in immunity) . Nat Med . 2000;6:680–685
  12. Mehal WZ , Azzaroli F , Crispe IN . Immunology of the healthy liver (old questions and new insights) . Gastroenterology . 2001;120:250–260
  13. Crispe IN . Hepatic T cells and liver tolerance . Nat Rev Immunol . 2003;3:51–62
  14. De Creus A , Abe M , Lau AH , Hackstein H , Raimondi G , Thomson AW . Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin . J Immunol . 2005;174:2037–2045
  15. Lichtman SN , Wang J , Lemasters JJ . LPS receptor CD14 participates in release of TNF-α in RAW 264.7 and peritoneal cells but not in Kupffer cells . Am J Physiol . 1998;275:G39–G46
  16. Zarember KA , Godowski PJ . Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines . J Immunol . 2002;168:554–561
  17. Gao JJ, Diesl V, Wittmann T, Morrison DC, Ryan JL, Vogel SN, et al. Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide . J Leukoc Biol . 2002;72:1234–1245
  18. Wells CA, Ravasi T, Faulkner GJ, Carninci P, Okazaki Y, Hayashizaki Y, et al. Genetic control of the innate immune response . BMC Immunol . 2003;4:5
  19. Haziot A, Ferrero E, Kontgen F, Hijiya N, Yamamoto S, Silver J, et al. Resistance to endotoxin shock and reduced dissemination of gram-negative bacteria in CD14-deficient mice . Immunity . 1996;4:407–414
  20. Jiang Z, Georgel P, Du X, Shamel L, Sovath S, Mudd S, et al. CD14 is required for MyD88-independent LPS signaling . Nat Immunol . 2005;6:565–570
  21. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, Akira S, et al. Essential role of MD-2 in LPS responsiveness and TLR4 distribution . Nat Immunol . 2002;3:667–672
  22. Visintin A , Mazzoni A , Spitzer JA , Segal DM . Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4 . Proc Natl Acad Sci U S A . 2001;98:12156–12161
  23. Ohnishi T , Muroi M , Tanamoto K . MD-2 is necessary for the toll-like receptor 4 protein to undergo glycosylation essential for its translocation to the cell surface . Clin Diagn Lab Immunol . 2003;10:405–410
  24. Schromm AB, Lien E, Henneke P, Chow JC, Yoshimura A, Heine H, et al. Molecular genetic analysis of an endotoxin nonresponder mutant cell line (a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling) . J Exp Med . 2001;194:79–88
  25. da Silva Correia J , Ulevitch RJ . MD-2 and TLR4 N-linked glycosylations are important for a functional lipopolysaccharide receptor . J Biol Chem . 2002;277:1845–1854
  26. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, et al. Structure and function of lipopolysaccharide binding protein . Science . 1990;249:1429–1431
  27. Hoebe K, Georgel P, Rutschmann S, Du X, Mudd S, Crozat K, et al. CD36 is a sensor of diacylglycerides . Nature . 2005;433:523–527
  28. Michel T , Reichhart JM , Hoffmann JA , Royet J . Drosophila Toll is activated by gram-positive bacteria through a circulating peptidoglycan recognition protein . Nature . 2001;414:756–759
  29. Tanji T , Ip YT . Regulators of the Toll and Imd pathways in the Drosophila innate immune response . Trends Immunol . 2005;26:193–198
  30. Kawai T , Adachi O , Ogawa T , Takeda K , Akira S . Unresponsiveness of MyD88-deficient mice to endotoxin . Immunity . 1999;11:115–122
  31. Horng T , Barton GM , Flavell RA , Medzhitov R . The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors . Nature . 2002;420:329–333
  32. Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4 . Nature . 2002;420:324–329
  33. Hoebe K, Du X, Georgel P, Janssen E, Tabeta K, Kim SO, et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling . Nature . 2003;424:743–748
  34. Yamamoto M, Sato S, Hemmi H, Hoshino K, Kaisho T, Sanjo H, et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway . Science . 2003;301:640–643
  35. Yamamoto M, Sato S, Hemmi H, Uematsu S, Hoshino K, Kaisho T, et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway . Nat Immunol . 2003;4:1144–1150
  36. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, et al. Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4 . Nature . 2002;416:750–756
  37. Swantek JL , Tsen MF , Cobb MH , Thomas JA . IL-1 receptor-associated kinase modulates host responsiveness to endotoxin . J Immunol . 2000;164:4301–4306
  38. Sato S, Sanjo H, Takeda K, Ninomiya-Tsuji J, Yamamoto M, Kawai T, et al. Essential function for the kinase TAK1 in innate and adaptive immune responses . Nat Immunol . 2005;6:1087–1095
  39. Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors . Nature . 2005;434:243–249
  40. Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S, et al. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity . Nat Immunol . 2005;6:587–592
  41. Covert MW , Leung TH , Gaston JE , Baltimore D . Achieving stability of lipopolysaccharide-induced NF-κB activation . Science . 2005;309:1854–1857
  42. Werner SL , Barken D , Hoffmann A . Stimulus specificity of gene expression programs determined by temporal control of IKK activity . Science . 2005;309:1857–1861
  43. Burns K , Janssens S , Brissoni B , Olivos N , Beyaert R , Tschopp J . Inhibition of interleukin 1 receptor/Toll-like receptor signaling through the alternatively spliced, short form of MyD88 is due to its failure to recruit IRAK-4 . J Exp Med . 2003;197:263–268
  44. Uematsu S, Sato S, Yamamoto M, Hirotani T, Kato H, Takeshita F, et al. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon (α) induction . J Exp Med . 2005;201:915–923
  45. Honda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, et al. IRF-7 is the master regulator of type-I interferon-dependent immune responses . Nature . 2005;434:772–777
  46. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, et al. IKKϵ and TBK1 are essential components of the IRF3 signaling pathway . Nat Immunol . 2003;4:491–496
  47. McWhirter SM , Fitzgerald KA , Rosains J , Rowe DC , Golenbock DT , Maniatis T . IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts . Proc Natl Acad Sci U S A . 2004;101:233–238
  48. Shimada T, Kawai T, Takeda K, Matsumoto M, Inoue J, Tatsumi Y, et al. IKK-i, a novel lipopolysaccharide-inducible kinase that is related to IκB kinases . Int Immunol . 1999;11:1357–1362
  49. Hemmi H, Takeuchi O, Sato S, Yamamoto M, Kaisho T, Sanjo H, et al. The roles of two IκB kinase-related kinases in lipopolysaccharide and double stranded RNA signaling and viral infection . J Exp Med . 2004;199:1641–1650
  50. Meylan E, Burns K, Hofmann K, Blancheteau V, Martinon F, Kelliher M, et al. RIP1 is an essential mediator of Toll-like receptor 3-induced NF-κB activation . Nat Immunol . 2004;5:503–507
  51. Sato S, Sugiyama M, Yamamoto M, Watanabe Y, Kawai T, Takeda K, et al. Toll/IL-1 receptor domain-containing adaptor inducing IFN-β (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-κB and IFN-regulatory factor-3, in the Toll-like receptor signaling . J Immunol . 2003;171:4304–4310
  52. Jiang Z , Zamanian-Daryoush M , Nie H , Silva AM , Williams BR , Li X . Poly(I-C)-induced Toll-like receptor 3 (TLR3)-mediated activation of NFκB and MAP kinase is through an interleukin-1 receptor-associated kinase (IRAK)-independent pathway employing the signaling components TLR3-TRAF6-TAK1-TAB2-PKR . J Biol Chem . 2003;278:16713–16719
  53. Gohda J , Matsumura T , Inoue J . Cutting edge (TNFR-associated factor (TRAF) 6 is essential for MyD88-dependent pathway but not toll/IL-1 receptor domain-containing adaptor-inducing IFN-β (TRIF)-dependent pathway in TLR signaling) . J Immunol . 2004;173:2913–2917
  54. Liew FY , Xu D , Brint EK , O’Neill LA . Negative regulation of toll-like receptor-mediated immune responses . Nat Rev Immunol . 2005;5:446–458
  55. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, Matsumoto M, et al. Cutting edge (endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression) . J Immunol . 2000;164:3476–3479
  56. Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, Kimoto M, et al. Cutting edge (cell surface expression and lipopolysaccharide signaling via the toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages) . J Immunol . 2000;164:3471–3475
  57. Chuang TH , Ulevitch RJ . Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors . Nat Immunol . 2004;5:495–502
  58. Brint EK, Xu D, Liu H, Dunne A, McKenzie AN, O’Neill LA, et al. ST2 is an inhibitor of interleukin 1 receptor and Toll-like receptor 4 signaling and maintains endotoxin tolerance . Nat Immunol . 2004;5:373–379
  59. Wald D, Qin J, Zhao Z, Qian Y, Naramura M, Tian L, et al. SIGIRR, a negative regulator of Toll-like receptor-interleukin 1 receptor signaling . Nat Immunol . 2003;4:920–927
  60. Janssens S , Burns K , Vercammen E , Tschopp J , Beyaert R . MyD88S, a splice variant of MyD88, differentially modulates NF-κB- and AP-1-dependent gene expression . FEBS Lett . 2003;548:103–107
  61. Kobayashi K , Hernandez LD , Galan JE , Janeway CA , Medzhitov R , Flavell RA . IRAK-M is a negative regulator of Toll-like receptor signaling . Cell . 2002;110:191–202
  62. Hardy MP , O’Neill LA . The murine IRAK2 gene encodes four alternatively spliced isoforms, two of which are inhibitory . J Biol Chem . 2004;279:27699–27708
  63. Nakagawa R, Naka T, Tsutsui H, Fujimoto M, Kimura A, Abe T, et al. SOCS-1 participates in negative regulation of LPS responses . Immunity . 2002;17:677–687
  64. Dalpke AH , Opper S , Zimmermann S , Heeg K . Suppressors of cytokine signaling (SOCS)-1 and SOCS-3 are induced by CpG-DNA and modulate cytokine responses in APCs . J Immunol . 2001;166:7082–7089
  65. Kinjyo I, Hanada T, Inagaki-Ohara K, Mori H, Aki D, Ohishi M, et al. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation . Immunity . 2002;17:583–591
  66. Su GL, Klein RD, Aminlari A, Zhang HY, Steinstraesser L, Alarcon WH, et al. Kupffer cell activation by lipopolysaccharide in rats (role for lipopolysaccharide binding protein and toll-like receptor 4) . Hepatology . 2000;31:932–936
  67. Van Bossuyt H , De Zanger RB , Wisse E . Cellular and subcellular distribution of injected lipopolysaccharide in rat liver and its inactivation by bile salts . J Hepatol . 1988;7:325–337
  68. Seki E, Tsutsui H, Nakano H, Tsuji N, Hoshino K, Adachi O, et al. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β . J Immunol . 2001;166:2651–2657
  69. Kopydlowski KM, Salkowski CA, Cody MJ, van Rooijen N, Major J, Hamilton TA, et al. Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo . J Immunol . 1999;163:1537–1544
  70. Tsutsui H , Matsui K , Okamura H , Nakanishi K . Pathophysiological roles of interleukin-18 in inflammatory liver diseases . Immunol Rev . 2000;174:192–209
  71. Seki E, Tsutsui H, Tsuji NM, Hayashi N, Adachi K, Nakano H, et al. Critical roles of myeloid differentiation factor 88-dependent proinflammatory cytokine release in early phase clearance of Listeria monocytogenes in mice . J Immunol . 2002;169:3863–3868
  72. Knolle P , Schlaak J , Uhrig A , Kempf P , Meyer zum Buschenfelde KH , Gerken G . Human Kupffer cells secrete IL-10 in response to lipopolysaccharide (LPS) challenge . J Hepatol . 1995;22:226–229
  73. Schuchmann M , Hermann F , Herkel J , van der Zee R , Galle PR , Lohse AW . HSP60 and CpG-DNA-oligonucleotides differentially regulate LPS-tolerance of hepatic Kupffer cells . Immunol Lett . 2004;93:199–204
  74. Matsumura T, Degawa T, Takii T, Hayashi H, Okamoto T, Inoue J, et al. TRAF6-NF-κB pathway is essential for interleukin-1-induced TLR2 expression and its functional response to TLR2 ligand in murine hepatocytes . Immunology . 2003;109:127–136
  75. Matsumura T , Ito A , Takii T , Hayashi H , Onozaki K . Endotoxin and cytokine regulation of toll-like receptor (TLR) 2 and TLR4 gene expression in murine liver and hepatocytes . J Interferon Cytokine Res . 2000;20:915–921
  76. Li K , Chen Z , Kato N , Gale M , Lemon SM . Distinct poly-I (C and virus-activated signaling pathways leading to interferon-β production in hepatocytes) . J Biol Chem . 2005;280:16739–16747
  77. Mimura Y , Sakisaka S , Harada M , Sata M , Tanikawa K . Role of hepatocytes in direct clearance of lipopolysaccharide in rats . Gastroenterology . 1995;109:1969–1976
  78. Hampton RY , Golenbock DT , Penman M , Krieger M , Raetz CR . Recognition and plasma clearance of endotoxin by scavenger receptors . Nature . 1991;352:342–344
  79. Vishnyakova TG, Bocharov AV, Baranova IN, Chen Z, Remaley AT, Csako G, et al. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1 . J Biol Chem . 2003;278:22771–22780
  80. Bataller R , Brenner DA . Liver fibrosis . J Clin Invest . 2005;115:209–218
  81. Paik YH , Schwabe RF , Bataller R , Russo MP , Jobin C , Brenner DA . Toll-like receptor 4 mediates inflammatory signaling by bacterial lipopolysaccharide in human hepatic stellate cells . Hepatology . 2003;37:1043–1055
  82. Brun P , Castagliuolo I , Pinzani M , Palu G , Martines D . Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cells . Am J Physiol Gastrointest Liver Physiol . 2005;289:G571–G578
  83. Thirunavukkarasu C , Uemura T , Wang LF , Watkins SC , Gandhi CR . Normal rat hepatic stellate cells respond to endotoxin in LBP-independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes . J Cell Physiol . 2005;204:654–665
  84. Harada K, Ohira S, Isse K, Ozaki S, Zen Y, Sato Y, et al. Lipopolysaccharide activates nuclear factor-κB through toll-like receptors and related molecules in cultured biliary epithelial cells . Lab Invest . 2003;83:1657–1667
  85. Chen XM, O’Hara SP, Nelson JB, Splinter PL, Small AJ, Tietz PS, et al. Multiple TLRs are expressed in human cholangiocytes and mediate host epithelial defense responses to Cryptosporidium parvum via activation of NF-κB . J Immunol . 2005;175:7447–7456
  86. Uhrig A, Banafsche R, Kremer M, Hegenbarth S, Hamann A, Neurath M, et al. Development and functional consequences of LPS tolerance in sinusoidal endothelial cells of the liver . J Leukoc Biol . 2005;77:626–633
  87. Bjarnason I , Peters TJ , Wise RJ . The leaky gut of alcoholism (possible route of entry for toxic compounds) . Lancet . 1984;1:179–182
  88. Draper LR , Gyure LA , Hall JG , Robertson D . Effect of alcohol on the integrity of the intestinal epithelium . Gut . 1983;24:399–404
  89. Parlesak A , Schafer C , Schutz T , Bode JC , Bode C . Increased intestinal permeability to macromolecules and endotoxemia in patients with chronic alcohol abuse in different stages of alcohol-induced liver disease . J Hepatol . 2000;32:742–747
  90. Nanji AA , Khettry U , Sadrzadeh SM . Lactobacillus feeding reduces endotoxemia and severity of experimental alcoholic liver (disease) . Proc Soc Exp Biol Med . 1994;205:243–247
  91. Adachi Y , Moore LE , Bradford BU , Gao W , Thurman RG . Antibiotics prevent liver injury in rats following long-term exposure to ethanol . Gastroenterology . 1995;108:218–224
  92. Adachi Y , Bradford BU , Gao W , Bojes HK , Thurman RG . Inactivation of Kupffer cells prevents early alcohol-induced liver injury . Hepatology . 1994;20:453–460
  93. Hansen J , Cherwitz DL , Allen JI . The role of tumor necrosis factor-α in acute endotoxin-induced hepatotoxicity in ethanol-fed rats . Hepatology . 1994;20:461–474
  94. Uesugi T , Froh M , Arteel GE , Bradford BU , Thurman RG . Toll-like receptor 4 is involved in the mechanism of early alcohol-induced liver injury in mice . Hepatology . 2001;34:101–108
  95. Kono H, Rusyn I, Yin M, Gabele E, Yamashina S, Dikalova A, et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease . J Clin Invest . 2000;106:867–872
  96. Yang SQ , Lin HZ , Lane MD , Clemens M , Diehl AM . Obesity increases sensitivity to endotoxin liver injury (implications for the pathogenesis of steatohepatitis) . Proc Natl Acad Sci U S A . 1997;94:2557–2562
  97. Solga SF , Diehl AM . Non-alcoholic fatty liver disease (lumen-liver interactions and possible role for probiotics) . J Hepatol . 2003;38:681–687
  98. Li Z, Yang S, Lin H, Huang J, Watkins PA, Moser AB, et al. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease . Hepatology . 2003;37:343–350
  99. Szabo G , Velayudham A , Romics L , Mandrekar P . Modulation of non-alcoholic steatohepatitis by pattern recognition receptors in mice (the role of toll-like receptors 2 and 4) . Alcohol Clin Exp Res . 2005;29:S140–S145
  100. Igolnikov AC , Spatz K , Green RM . C3H/HeJ mice with mutations of the toll-like receptor 4 (TLR-4) are resistant to methionine-choline deficient (MCD) diet induced non-alcoholic steatohepatitis (NASH) . Hepatology . 2002;36:A965
  101. Wiest R , Garcia-Tsao G . Bacterial translocation (BT) in cirrhosis . Hepatology . 2005;41:422–433
  102. Chesta J , Defilippi C , Defilippi C . Abnormalities in proximal small bowel motility in patients with cirrhosis . Hepatology . 1993;17:828–832
  103. Guarner C , Runyon BA , Young S , Heck M , Sheikh MY . Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites . J Hepatol . 1997;26:1372–1378
  104. Ramachandran A , Prabhu R , Thomas S , Reddy JB , Pulimood A , Balasubramanian KA . Intestinal mucosal alterations in experimental cirrhosis in the rat (role of oxygen free radicals) . Hepatology . 2002;35:622–629
  105. Rajkovic IA , Williams R . Abnormalities of neutrophil phagocytosis, intracellular killing and metabolic activity in alcoholic cirrhosis and hepatitis . Hepatology . 1986;6:252–262
  106. Garcia-Tsao G , Lee FY , Barden GE , Cartun R , West AB . Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites . Gastroenterology . 1995;108:1835–1841
  107. Nolan JP , Leibowitz AI . Endotoxin and the liver. III. Modification of acute carbon tetrachloride injury by polymyxin b—an antiendotoxin . Gastroenterology . 1978;75:445–449
  108. Grinko I , Geerts A , Wisse E . Experimental biliary fibrosis correlates with increased numbers of fat-storing and Kupffer cells, and portal endotoxemia . J Hepatol . 1995;23:449–458
  109. Chan CC, Hwang SJ, Lee FY, Wang SS, Chang FY, Li CP, et al. Prognostic value of plasma endotoxin levels in patients with cirrhosis . Scand J Gastroenterol . 1997;32:942–946
  110. Fukui H , Brauner B , Bode JC , Bode C . Plasma endotoxin concentrations in patients with alcoholic and non-alcoholic liver disease (reevaluation with an improved chromogenic assay) . J Hepatol . 1991;12:162–169
  111. Lin RS, Lee FY, Lee SD, Tsai YT, Lin HC, Lu RH, et al. Endotoxemia in patients with chronic liver diseases (relationship to severity of liver diseases, presence of esophageal varices, and hyperdynamic circulation) . J Hepatol . 1995;22:165–172
  112. Luckey TD , Reyniers JA , Gyorgy P , Forbes M . Germfree animals and liver necrosis . Ann N Y Acad Sci . 1954;57:932–935
  113. Rutenburg AM , Sonnenblick E , Koven I , Aprahamian HA , Reiner L , Fine J . The role of intestinal bacteria in the development of dietary cirrhosis in rats . J Exp Med . 1957;106:1–14
  114. Seki E , Osawa Y , Uchinami H , Brenner DA , Schwabe RF . TLR4 mediates inflammation and fibrogenesis after bile duct ligation . Hepatology . 2005;42:A265
  115. Dolganiuc A, Oak S, Kodys K, Golenbock DT, Finberg RW, Kurt-Jones E, et al. Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation . Gastroenterology . 2004;127:1513–1524
  116. Bataller R , Paik YH , Lindquist JN , Lemasters JJ , Brenner DA . Hepatitis C virus core and nonstructural proteins induce fibrogenic effects in hepatic stellate cells . Gastroenterology . 2004;126:529–540
  117. Wieland S , Thimme R , Purcell RH , Chisari FV . Genomic analysis of the host response to hepatitis B virus infection . Proc Natl Acad Sci U S A . 2004;101:6669–6674
  118. McClary H , Koch R , Chisari FV , Guidotti LG . Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines . J Virol . 2000;74:2255–2264
  119. Isogawa M , Robek MD , Furuichi Y , Chisari FV . Toll-like receptor signaling inhibits hepatitis B virus replication in vivo . J Virol . 2005;79:7269–7272
  120. Cooper CL, Davis HL, Morris ML, Efler SM, Adhami MA, Krieg AM, et al. CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B HBV vaccine in healthy adults (a double-blind phase I/II study) . J Clin Immunol . 2004;24:693–701
  121. Rehermann B , Nascimbeni M . Immunology of hepatitis B virus and hepatitis C virus infection . Nat Rev Immunol . 2005;5:215–229
  122. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, et al. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF . Proc Natl Acad Sci U S A . 2005;102:2992–2997
  123. Otsuka M, Kato N, Moriyama M, Taniguchi H, Wang Y, Dharel N, et al. Interaction between the HCV NS3 protein and the host TBK1 protein leads to inhibition of cellular antiviral responses . Hepatology . 2005;41:1004–1012
  124. Machida K , Cheng KT , Sung VM , Levine AM , Foung S , Lai MM . Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of Beta interferon and interleukin-6 . J Virol . 2006;80:866–874
  125. Horsmans Y, Berg T, Desager JP, Mueller T, Schott E, Fletcher SP, et al. Isatoribine, an agonist of TLR7, reduces plasma virus concentration in chronic hepatitis C infection . Hepatology . 2005;42:724–731
  126. Zhai Y, Shen XD, O’Connell R, Gao F, Lassman C, Busuttil RW, et al. Cutting edge (TLR4 activation mediates liver ischemia/reperfusion inflammatory response via IFN regulatory factor 3-dependent MyD88-independent pathway) . J Immunol . 2004;173:7115–7119
  127. Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, et al. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion . J Exp Med . 2005;201:1135–1143
  128. Taub R . Liver regeneration (from myth to mechanism) . Nat Rev Mol Cell Biol . 2004;5:836–847
  129. Higgins GM , Anderson RM . Experimental pathology of the liver. I. Restoration of the liver of the white rat following partial surgical removal . Arch Pathol . 1931;12:186–202
  130. Cornell RP , Liljequist BL , Bartizal KF . Depressed liver regeneration after partial hepatectomy of germ-free, athymic and lipopolysaccharide-resistant mice . Hepatology . 1990;11:916–922
  131. Su GL , Wang SC , Aminlari A , Tipoe GL , Steinstraesser L , Nanji A . Impaired hepatocyte regeneration in toll-like receptor 4 mutant mice . Dig Dis Sci . 2004;49:843–849
  132. Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, et al. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration . Hepatology . 2005;41:443–450
  133. Sun R , Gao B . Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-gamma) . Gastroenterology . 2004;127:1525–1539
  134. Shimizu Y , Margenthaler JA , Landeros K , Otomo N , Doherty G , Flye MW . The resistance of P. acnes—primed interferon γ-deficient mice to low-dose lipopolysaccharide-induced acute liver injury . Hepatology . 2002;35:805–814
  135. Galanos C , Freudenberg MA , Reutter W . Galactosamine-induced sensitization to the lethal effects of endotoxin . Proc Natl Acad Sci U S A . 1979;76:5939–5943
  136. Jiang W , Sun R , Wei H , Tian Z . Toll-like receptor 3 ligand attenuates LPS-induced liver injury by down-regulation of toll-like receptor 4 expression on macrophages . Proc Natl Acad Sci U S A . 2005;102:17077–17082
  137. Tsuji H, Mukaida N, Harada A, Kaneko S, Matsushita E, Nakanuma Y, et al. Alleviation of lipopolysaccharide-induced acute liver injury in Propionibacterium acnes-primed IFN-γ-deficient mice by a concomitant reduction of TNF-α, IL-12, and IL-18 production . J Immunol . 1999;162:1049–1055
  138. Tsutsui H, Matsui K, Kawada N, Hyodo Y, Hayashi N, Okamura H, et al. IL-18 accounts for both TNF-α- and Fas ligand-mediated hepatotoxic pathways in endotoxin-induced liver injury in mice . J Immunol . 1997;159:3961–3967
  139. Kalis C, Gumenscheimer M, Freudenberg N, Tchaptchet S, Fejer G, Heit A, et al. Requirement for TLR9 in the immunomodulatory activity of Propionibacterium acnes . J Immunol . 2005;174:4295–4300
  140. Romics L, Dolganiuc A, Velayudham A, Kodys K, Mandrekar P, Golenbock D, et al. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propionibacterium acnes . J Leukoc Biol . 2005;78:1255–1264
  141. Romics L, Dolganiuc A, Kodys K, Drechsler Y, Oak S, Velayudham A, et al. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice . Hepatology . 2004;40:555–564
  142. Edelson BT , Unanue ER . MyD88-dependent but Toll-like receptor 2-independent innate immunity to Listeria (no role for either in macrophage listericidal activity) . J Immunol . 2002;169:3869–3875
  143. O’Brien AD , Rosenstreich DL , Scher I , Campbell GH , MacDermott RP , Formal SB . Genetic control of susceptibility to Salmonella typhimurium in mice (role of the LPS gene) . J Immunol . 1980;124:20–24
  144. Vazquez-Torres A, Vallance BA, Bergman MA, Finlay BB, Cookson BT, Jones-Carson J, et al. Toll-like receptor 4 dependence of innate and adaptive immunity to Salmonella (importance of the Kupffer cell network) . J Immunol . 2004;172:6202–6208
  145. Totemeyer S , Foster N , Kaiser P , Maskell DJ , Bryant CE . Toll-like receptor expression in C3H/HeN and C3H/HeJ mice during Salmonella enterica serovar Typhimurium infection . Infect Immun . 2003;71:6653–6657
  146. Shimizu H, Matsuguchi T, Fukuda Y, Nakano I, Hayakawa T, Takeuchi O, et al. Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice . Gastroenterology . 2002;123:1265–1277
  147. Adachi K, Tsutsui H, Kashiwamura S, Seki E, Nakano H, Takeuchi O, et al. Plasmodium berghei infection in mice induces liver injury by an IL-12- and toll-like receptor/myeloid differentiation factor 88-dependent mechanism . J Immunol . 2001;167:5928–5934
  148. Bach JF . A Toll-like trigger for autoimmune disease . Nat Med . 2005;11:120–121
  149. Kerfoot SM, Long EM, Hickey MJ, Andonegui G, Lapointe BM, Zanardo RC, et al. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease . J Immunol . 2004;173:7070–7077
  150. Lang KS, Recher M, Junt T, Navarini AA, Harris NL, Freigang S, et al. Toll-like receptor engagement converts T-cell autoreactivity into overt autoimmune disease . Nat Med . 2005;11:138–145
  151. Patole PS, Grone HJ, Segerer S, Ciubar R, Belemezova E, Henger A, et al. Viral double-stranded RNA aggravates Lupus Nephritis through Toll-like receptor 3 on glomerular mesangial cells and antigen-presenting cells . J Am Soc Nephrol . 2005;16:1326–1338
  152. Takii Y, Nakamura M, Ito M, Yokoyama T, Komori A, Shimizu-Yoshida Y, et al. Enhanced expression of type I interferon and toll-like receptor-3 in primary biliary cirrhosis . Lab Invest . 2005;85:908–920
  153. Wang AP, Migita K, Ito M, Takii Y, Daikoku M, Yokoyama T, et al. Hepatic expression of toll-like receptor 4 in primary biliary cirrhosis . J Autoimmun . 2005;25:85–91
  154. Mao TK, Lian ZX, Selmi C, Ichiki Y, Ashwood P, Ansari AA, et al. Altered monocyte responses to defined TLR ligands in patients with primary biliary cirrhosis . Hepatology . 2005;42:802–808
  155. Kikuchi K, Lian ZX, Yang GX, Ansari AA, Ikehara S, Kaplan M, et al. Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis . Gastroenterology . 2005;128:304–312
  156. Kikuchi K, Lian ZX, Kimura Y, Selmi C, Yang GX, Gordon SC, et al. Genetic polymorphisms of toll-like receptor 9 influence the immune response to CpG and contribute to hyper-IgM in primary biliary cirrhosis . J Autoimmun . 2005;24:347–352

 Supported by a Research Scholar Award from the American Gastroenterological Association and Procter & Gamble (to R.F.S.).

PII: S0016-5085(06)00065-5

doi: 10.1053/j.gastro.2006.01.038

Gastroenterology
Volume 130, Issue 6 , Pages 1886-1900 , May 2006

Article Tools

* Image Usage & Resolution